CARL ZEISS MEDITEC AG - BR (1AFX.MI) Stock Fundamental Analysis
Europe - BIT:1AFX - DE0005313704 - Common Stock
42.78 EUR
-0.08 (-0.19%)
1AFX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. 1AFX has only an average score on both its financial health and profitability. 1AFX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1AFX was profitable.
1AFX had a positive operating cash flow in the past year.
Each year in the past 5 years 1AFX has been profitable.
In the past 5 years 1AFX always reported a positive cash flow from operatings.
1.2 Ratios
1AFX has a Return On Assets of 4.49%. This is in the better half of the industry: 1AFX outperforms 67.80% of its industry peers.
The Return On Equity of 1AFX (7.51%) is better than 66.10% of its industry peers.
The Return On Invested Capital of 1AFX (4.74%) is comparable to the rest of the industry.
1AFX had an Average Return On Invested Capital over the past 3 years of 9.30%. This is in line with the industry average of 8.90%.
The 3 year average ROIC (9.30%) for 1AFX is well above the current ROIC(4.74%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.49% | ||
| ROE | 7.51% | ||
| ROIC | 4.74% |
ROA(3y)8.42%
ROA(5y)8.24%
ROE(3y)12.26%
ROE(5y)11.91%
ROIC(3y)9.3%
ROIC(5y)9.86%
1.3 Margins
With a Profit Margin value of 7.19%, 1AFX perfoms like the industry average, outperforming 57.63% of the companies in the same industry.
In the last couple of years the Profit Margin of 1AFX has declined.
The Operating Margin of 1AFX (8.55%) is comparable to the rest of the industry.
1AFX's Operating Margin has declined in the last couple of years.
1AFX's Gross Margin of 52.43% is in line compared to the rest of the industry. 1AFX outperforms 47.46% of its industry peers.
In the last couple of years the Gross Margin of 1AFX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.55% | ||
| PM (TTM) | 7.19% | ||
| GM | 52.43% |
OM growth 3Y-25.26%
OM growth 5Y-12.3%
PM growth 3Y-15.52%
PM growth 5Y-4.6%
GM growth 3Y-3.56%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
1AFX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1AFX has less shares outstanding
The number of shares outstanding for 1AFX has been reduced compared to 5 years ago.
The debt/assets ratio for 1AFX is higher compared to a year ago.
2.2 Solvency
1AFX has an Altman-Z score of 3.27. This indicates that 1AFX is financially healthy and has little risk of bankruptcy at the moment.
1AFX has a better Altman-Z score (3.27) than 62.71% of its industry peers.
1AFX has a debt to FCF ratio of 7.17. This is a slightly negative value and a sign of low solvency as 1AFX would need 7.17 years to pay back of all of its debts.
1AFX has a Debt to FCF ratio of 7.17. This is comparable to the rest of the industry: 1AFX outperforms 54.24% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that 1AFX is not too dependend on debt financing.
1AFX has a Debt to Equity ratio (0.27) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 7.17 | ||
| Altman-Z | 3.27 |
ROIC/WACC0.7
WACC6.79%
2.3 Liquidity
A Current Ratio of 2.04 indicates that 1AFX has no problem at all paying its short term obligations.
1AFX has a better Current ratio (2.04) than 61.02% of its industry peers.
1AFX has a Quick Ratio of 1.17. This is a normal value and indicates that 1AFX is financially healthy and should not expect problems in meeting its short term obligations.
1AFX has a Quick ratio (1.17) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.04 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The earnings per share for 1AFX have decreased strongly by -25.00% in the last year.
1AFX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.35% yearly.
1AFX shows a small growth in Revenue. In the last year, the Revenue has grown by 5.50%.
1AFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.20% yearly.
EPS 1Y (TTM)-25%
EPS 3Y-8.8%
EPS 5Y2.35%
EPS Q2Q%-15.79%
Revenue 1Y (TTM)5.5%
Revenue growth 3Y7.85%
Revenue growth 5Y7.2%
Sales Q2Q%1.92%
3.2 Future
The Earnings Per Share is expected to grow by 14.24% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.71% on average over the next years.
EPS Next Y-10.07%
EPS Next 2Y5.58%
EPS Next 3Y10.88%
EPS Next 5Y14.24%
Revenue Next Year6.27%
Revenue Next 2Y5.68%
Revenue Next 3Y6.17%
Revenue Next 5Y6.71%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.02, 1AFX can be considered very expensive at the moment.
1AFX's Price/Earnings ratio is a bit cheaper when compared to the industry. 1AFX is cheaper than 72.88% of the companies in the same industry.
1AFX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.38.
A Price/Forward Earnings ratio of 19.09 indicates a rather expensive valuation of 1AFX.
Based on the Price/Forward Earnings ratio, 1AFX is valued a bit cheaper than 71.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1AFX to the average of the S&P500 Index (22.86), we can say 1AFX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.02 | ||
| Fwd PE | 19.09 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1AFX is valued a bit cheaper than 74.58% of the companies in the same industry.
1AFX's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 46.12 | ||
| EV/EBITDA | 12.81 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)10.67
EPS Next 2Y5.58%
EPS Next 3Y10.88%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.33%, 1AFX has a reasonable but not impressive dividend return.
1AFX's Dividend Yield is a higher than the industry average which is at 2.23.
Compared to an average S&P500 Dividend Yield of 2.38, 1AFX's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
5.2 History
The dividend of 1AFX is nicely growing with an annual growth rate of 15.07%!
Dividend Growth(5Y)15.07%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
1AFX pays out 33.69% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1AFX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.69%
EPS Next 2Y5.58%
EPS Next 3Y10.88%
BIT:1AFX (9/10/2025, 7:00:00 PM)
42.78
-0.08 (-0.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners21.46%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.83B
Analysts72.73
Price Target55.89 (30.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
Yearly Dividend1.11
Dividend Growth(5Y)15.07%
DP33.69%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.71%
Min EPS beat(2)-36.67%
Max EPS beat(2)13.25%
EPS beat(4)2
Avg EPS beat(4)-5.53%
Min EPS beat(4)-36.67%
Max EPS beat(4)37.18%
EPS beat(8)6
Avg EPS beat(8)8.89%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.29%
Min Revenue beat(2)0.82%
Max Revenue beat(2)3.76%
Revenue beat(4)3
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)3.76%
Revenue beat(8)5
Avg Revenue beat(8)-0.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.32%
PT rev (3m)-11.98%
EPS NQ rev (1m)-15.53%
EPS NQ rev (3m)-15.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.23%
Revenue NQ rev (1m)-2.4%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.02 | ||
| Fwd PE | 19.09 | ||
| P/S | 1.76 | ||
| P/FCF | 46.12 | ||
| P/OCF | 19.56 | ||
| P/B | 1.84 | ||
| P/tB | 9.86 | ||
| EV/EBITDA | 12.81 |
EPS(TTM)1.71
EY4%
EPS(NY)2.24
Fwd EY5.24%
FCF(TTM)0.93
FCFY2.17%
OCF(TTM)2.19
OCFY5.11%
SpS24.26
BVpS23.21
TBVpS4.34
PEG (NY)N/A
PEG (5Y)10.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.49% | ||
| ROE | 7.51% | ||
| ROCE | 6.52% | ||
| ROIC | 4.74% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 12.2% | ||
| OM | 8.55% | ||
| PM (TTM) | 7.19% | ||
| GM | 52.43% | ||
| FCFM | 3.82% |
ROA(3y)8.42%
ROA(5y)8.24%
ROE(3y)12.26%
ROE(5y)11.91%
ROIC(3y)9.3%
ROIC(5y)9.86%
ROICexc(3y)9.4%
ROICexc(5y)9.93%
ROICexgc(3y)15.11%
ROICexgc(5y)14.85%
ROCE(3y)12.78%
ROCE(5y)13.55%
ROICexcg growth 3Y-11.32%
ROICexcg growth 5Y-4.61%
ROICexc growth 3Y-28.53%
ROICexc growth 5Y-15.22%
OM growth 3Y-25.26%
OM growth 5Y-12.3%
PM growth 3Y-15.52%
PM growth 5Y-4.6%
GM growth 3Y-3.56%
GM growth 5Y-1.56%
F-Score4
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 7.17 | ||
| Debt/EBITDA | 1.68 | ||
| Cap/Depr | 73.33% | ||
| Cap/Sales | 5.19% | ||
| Interest Coverage | 13.7 | ||
| Cash Conversion | 57.69% | ||
| Profit Quality | 53.21% | ||
| Current Ratio | 2.04 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 3.27 |
F-Score4
WACC6.79%
ROIC/WACC0.7
Cap/Depr(3y)128.62%
Cap/Depr(5y)113.53%
Cap/Sales(3y)5.71%
Cap/Sales(5y)4.9%
Profit Quality(3y)45.51%
Profit Quality(5y)74.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3Y-8.8%
EPS 5Y2.35%
EPS Q2Q%-15.79%
EPS Next Y-10.07%
EPS Next 2Y5.58%
EPS Next 3Y10.88%
EPS Next 5Y14.24%
Revenue 1Y (TTM)5.5%
Revenue growth 3Y7.85%
Revenue growth 5Y7.2%
Sales Q2Q%1.92%
Revenue Next Year6.27%
Revenue Next 2Y5.68%
Revenue Next 3Y6.17%
Revenue Next 5Y6.71%
EBIT growth 1Y-40.66%
EBIT growth 3Y-19.39%
EBIT growth 5Y-5.98%
EBIT Next Year68.13%
EBIT Next 3Y30.52%
EBIT Next 5Y20.62%
FCF growth 1Y-30.57%
FCF growth 3Y-31.55%
FCF growth 5Y-11.27%
OCF growth 1Y-1.41%
OCF growth 3Y-11.98%
OCF growth 5Y2.4%